Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2022-05-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過111年第一季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) reporting the board's approval of the consolidated financial report for the first quarter of 2022 (111/01/01 to 111/03/31). It includes detailed financial figures such as revenue, gross profit, operating profit, net profit, total assets, liabilities, and equity for the quarter. The document is 907 characters long, which is relatively short but contains substantive financial data and analysis for a quarterly period. It is not merely an announcement that a report is available, nor is it a certification or attestation. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-05-10 Chinese
111年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (中化生) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it announce or attach a full report. The content is regulatory in nature, providing compliance information about financial guarantees and loans, typical of a regulatory filing. The document length is very short (602 characters), and it does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains actual data, but the data is limited and regulatory. Therefore, the best classification is Regulatory Filings (RNS).
2022-05-10 Chinese
111年4月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, with comparisons to the previous year and explanations for changes. It contains financial data for a specific month (April 2022) and cumulative year-to-date figures. The document is short (790 characters) and appears to be a periodic financial summary rather than a full annual or quarterly report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more consistent with a brief financial update or factsheet. Given the concise nature and focus on key financial figures, the best fitting category is Fund Information / Factsheet (FS).
2022-05-10 Chinese
更新私募專區-董事會決議日起兩日內應申報相關資訊(私募轉換 公司債適用)
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (中化生) regarding updates to private placement conditions for convertible bonds. It details changes in issuance terms and the rationale for pricing adjustments. The content is focused on disclosure of financing terms and regulatory compliance rather than a full financial report or earnings release. The document length is short (1740 characters) and it is an announcement of updated private placement terms, not a full report or financial statement. Therefore, it fits best under Capital/Financing Update (CAP).
2022-04-20 Chinese
修訂辦理私募發行國內可轉換公司債（包括有擔保或無擔保 可轉換公司債）發行條件。
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a company regarding the revision of conditions for a private placement of domestic convertible bonds. It includes details such as board resolution date, bond name, issuance amount, pricing, terms, and authorization requests for the board to handle issuance and related matters. The document is short (1720 characters) and primarily serves as an official notification of financing plans and authorizations rather than a detailed financial report or presentation. It does not contain actual financial statements or comprehensive financial analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2022-04-20 Chinese
111年04月法人說明會簡報 — 176220220412E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Fourth Quarter 2021 Investor Conference' and dated April 13, 2022. It contains detailed financial data including consolidated income statements, balance sheets, sales distribution, profitability over 5 years, and future outlook. It also includes company highlights, product information, and strategic plans. The presence of comprehensive financial statements and analysis for the quarter ending 2021 indicates this is a quarterly or interim report rather than a brief earnings release or an investor presentation. The length of the document (8281 characters) and the detailed financial data support classification as an Interim / Quarterly Report (IR).
2022-04-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.